Company details

HEADCOUNT

100-499

ORG TYPE

Startup

SECTOR

Healthcare & Life Sciences

WEBSITE

https://www.artiospharma.com

About the company

Artios Pharma is a Cambridge-area oncology biotech focused on DNA Damage Response targets, developing small-molecule therapies for cancer. Public role pages describe programmes in early phases of clinical development, including studies of an ATR inhibitor (ART0380) and a Polθ inhibitor (ART4215). The company operates from the Babraham Research Campus and has been funded as a venture-backed biotech since at least its Series B financing in 2018. Public employee feedback tends to focus on the science-first environment and team culture, with recurring comments that pay is only “okay” at some levels.

Locations and presence

Artios Pharma is based at the Babraham Research Campus near Cambridge. LinkedIn also lists a New York address, suggesting a small US-facing footprint alongside the UK scientific hub.

Palpable Score

61.5

/ 100

Artios Pharma offers real early-career entry points in lab operations and internships, but the visible pathway is narrow and tends to sit in technical support rather than a broad graduate intake. The strongest signals are culture and day-to-day support around learning on the job, while pay transparency and published progression outcomes are limited.

Pillar 1: Early-career access

Score

12.0

/ 20

The company has advertised a Junior Laboratory Technician role aimed at early-career candidates, with A-levels and a biological science degree listed as desirable rather than strict barriers.
Artios Pharma has also advertised internships, including a 6-month Cell and Molecular Biology placement that expects a BSc or MSc plus baseline lab experience.
The company’s publicly visible hiring leans heavily toward scientist and senior scientist roles, so consistent 0–3 year hiring volume is hard to evidence.

Pillar 2: Hiring fairness and transparency

Score

13.0

/ 20

The company’s public interview feedback describes a straightforward flow: screening call, then a panel interview with a role-relevant presentation and Q&A, plus situational working-style questions.
Artios Pharma has an external interview snapshot on Indeed that rates the experience favourably and “easy,” but it is based on fewer than 10 interviews so confidence is capped.
The company’s early-career listings that are publicly visible do not consistently publish salary ranges or time-boxed assessment expectations, which limits transparency for first-time applicants.

Pillar 3: Learning and support

Score

13.0

/ 20

The company’s internship description explicitly includes learning new techniques, contributing data to live discovery projects, and collaborating with external scientists and academics.
Artios Pharma’s technician-style role scope is practical and skills-building, covering lab logistics, maintenance, shipments, and database upkeep that can set someone up for larger lab operations responsibility.
The company has limited public detail on structured onboarding, mentoring assignments, or progression frameworks for junior hires beyond “join a growing research team” language.

Pillar 4: Pay fairness and stability

Score

11.0

/ 20

The company receives strong compensation-and-benefits category scores on Glassdoor, suggesting employees see the overall package as decent even with a small sample size.
Artios Pharma has repeated employee-review comments that pay is “okay, not great” and could be better at lower or mid scientific levels, which is a fairness risk for early-career earners.
The company’s publicly visible job ads and third-party reposts rarely include salary bands, so candidates often cannot benchmark the offer before committing time to interviews.

Pillar 5: Early-career outcomes

Score

12.5

/ 20

The company has a high overall Glassdoor rating and a 100% “recommend to a friend” snapshot, including positive reviews from scientists and an “Intern – scientist” review describing a relaxed atmosphere and good people.
Artios Pharma also has a recurring internal-outcome caution in reviews: at least one employee flags limited progression, which matters for early-career growth over 18–24 months.
The company’s LinkedIn footprint indicates a UK hub plus a small US presence, but public data on junior promotions, retention, or intern-to-full-time conversion is not published.